An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders
Authors
Keywords
-
Journal
Nature Reviews Neurology
Volume 16, Issue 5, Pages 265-284
Publisher
Springer Science and Business Media LLC
Online
2020-04-23
DOI
10.1038/s41582-020-0348-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia
- (2020) Carolin Heller et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia
- (2020) Shorena Janelidze et al. NATURE MEDICINE
- Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration
- (2020) Elisabeth H. Thijssen et al. NATURE MEDICINE
- Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts
- (2020) Thomas K Karikari et al. LANCET NEUROLOGY
- Glial Fibrillary Acidic Protein in Serum is Increased in Alzheimer’s Disease and Correlates with Cognitive Impairment
- (2019) Patrick Oeckl et al. JOURNAL OF ALZHEIMERS DISEASE
- Tau PET imaging in neurodegenerative tauopathies—still a challenge
- (2019) Antoine Leuzy et al. MOLECULAR PSYCHIATRY
- Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk
- (2019) Iris E. Jansen et al. NATURE GENETICS
- Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease
- (2019) Oliver Preische et al. NATURE MEDICINE
- Increased DJ-1 and α-Synuclein in Plasma Neural-Derived Exosomes as Potential Markers for Parkinson’s Disease
- (2019) Zhen-Hua Zhao et al. Frontiers in Aging Neuroscience
- Utility of Neuronal-Derived Exosomes to Examine Molecular Mechanisms That Affect Motor Function in Patients With Parkinson Disease
- (2019) Dilan Athauda et al. JAMA Neurology
- Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration
- (2019) Nicholas J. Ashton et al. Acta Neuropathologica Communications
- Autoradiography validation of novel tau PET tracer [F-18]-MK-6240 on human postmortem brain tissue
- (2019) Cinthya Aguero et al. Acta Neuropathologica Communications
- A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer’s disease
- (2019) Nicholas J. Ashton et al. Science Advances
- Assessment of Plasma Total Tau Level as a Predictive Biomarker for Dementia and Related Endophenotypes
- (2019) Matthew P. Pase et al. JAMA Neurology
- Urate and Homocysteine: Predicting Motor and Cognitive Changes in Newly Diagnosed Parkinson’s Disease
- (2019) Isobel Sleeman et al. Journal of Parkinsons Disease
- 18F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes
- (2019) Richard M. Tsai et al. Alzheimers Research & Therapy
- Systematic Review of miRNA as Biomarkers in Alzheimer’s Disease
- (2019) S. Swarbrick et al. MOLECULAR NEUROBIOLOGY
- Synaptic vesicle protein 2A as a potential biomarker in synaptopathies
- (2019) Kerstin Heurling et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- α‐Synuclein real‐time quaking‐induced conversion in the cerebrospinal fluid of uncertain cases of parkinsonism
- (2019) Anouke van Rumund et al. ANNALS OF NEUROLOGY
- Neurofilament light chain as a biomarker in neurological disorders
- (2019) Lorenzo Gaetani et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Conversion to MCI and dementia in Parkinson's disease: a systematic review and meta-analysis
- (2019) Dimitrios Saredakis et al. PARKINSONISM & RELATED DISORDERS
- 18F-Flortaucipir in TDP-43 associated frontotemporal dementia
- (2019) R. Smith et al. Scientific Reports
- Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease
- (2019) Oskar Hansson et al. Alzheimers Research & Therapy
- Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease
- (2019) Niklas Mattsson et al. JAMA Neurology
- Correlations between serum and CSF pNfH levels in ALS, FTD and controls: a comparison of three analytical approaches
- (2019) Carlo Wilke et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Neurofilament levels in patients with neurological diseases: A comparison of neurofilament light and heavy chain levels
- (2019) Pavlína Kušnierová et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease–Related β-Amyloid Status
- (2019) Sebastian Palmqvist et al. JAMA Neurology
- Establishment of neurofilament light chain Simoa assay in cerebrospinal fluid and blood
- (2019) Robert Hendricks et al. Bioanalysis
- Neurofilaments in pre-symptomatic ALS and the impact of genotype
- (2019) Michael Benatar et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Serum Neurofilament Light Chain Levels in Patients With Presymptomatic Multiple Sclerosis
- (2019) Kjetil Bjornevik et al. JAMA Neurology
- Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
- (2019) Sebastian Palmqvist et al. EMBO Molecular Medicine
- Association between plasma GFAP concentrations and MRI abnormalities in patients with CT-negative traumatic brain injury in the TRACK-TBI cohort: a prospective multicentre study
- (2019) John K Yue et al. LANCET NEUROLOGY
- α‐Synuclein RT‐QuIC assay in cerebrospinal fluid of patients with dementia with Lewy bodies
- (2019) Matilde Bongianni et al. Annals of Clinical and Translational Neurology
- Cerebrospinal fluid levels of neurogranin in Parkinsonian disorders
- (2019) Sara Hall et al. MOVEMENT DISORDERS
- Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology
- (2018) Erik Portelius et al. ACTA NEUROPATHOLOGICA
- Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography
- (2018) Michelle M. Mielke et al. Alzheimers & Dementia
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- The Glymphatic System in Central Nervous System Health and Disease: Past, Present, and Future
- (2018) Benjamin A. Plog et al. Annual Review of Pathology-Mechanisms of Disease
- Update on biomarkers for amyloid pathology in Alzheimer's disease
- (2018) Nicholas J Ashton et al. Biomarkers in Medicine
- Serum metabolomics study in a group of Parkinson's disease patients from northern India
- (2018) G. Nagesh Babu et al. CLINICA CHIMICA ACTA
- Commutability of the certified reference materials for the standardization of β-amyloid 1-42 assay in human cerebrospinal fluid: lessons for tau and β-amyloid 1-40 measurements
- (2018) Ulf Andreasson et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Assay of Plasma Phosphorylated Tau Protein (Threonine 181) and Total Tau Protein in Early-Stage Alzheimer’s Disease
- (2018) Che-Chuan Yang et al. JOURNAL OF ALZHEIMERS DISEASE
- Potential biomarkers of Parkinson's disease revealed by plasma metabolic profiling
- (2018) Huiyuan Zhao et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Neurofilament light chain and tau concentrations are markedly increased in the serum of patients with sporadic Creutzfeldt-Jakob disease, and tau correlates with rate of disease progression
- (2018) Andrew Geoffrey Bourne Thompson et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Plasma tau is increased in frontotemporal dementia
- (2018) Martha S Foiani et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- First in-human PET study of 3 novel tau radiopharmaceuticals: [11C]RO6924963, [11C]RO6931643, and [18F]RO6958948
- (2018) Dean F. Wong et al. JOURNAL OF NUCLEAR MEDICINE
- Alternations of Metabolic Profile and Kynurenine Metabolism in the Plasma of Parkinson’s Disease
- (2018) Kuo-Hsuan Chang et al. MOLECULAR NEUROBIOLOGY
- High performance plasma amyloid-β biomarkers for Alzheimer’s disease
- (2018) Akinori Nakamura et al. NATURE
- No association of salivary total tau concentration with Alzheimer's disease
- (2018) Nicholas J. Ashton et al. NEUROBIOLOGY OF AGING
- The relation between plasma α-synuclein level and clinical symptoms or signs of Parkinson's disease
- (2018) Michalina Malec-Litwinowicz et al. Neurologia i Neurochirurgia Polska
- Plasma neurofilament light chain concentration in the inherited peripheral neuropathies
- (2018) Åsa Sandelius et al. NEUROLOGY
- Serum neurofilament light chain in progressive supranuclear palsy
- (2018) Laura Donker Kaat et al. PARKINSONISM & RELATED DISORDERS
- Neurofilament light as a blood biomarker for neurodegeneration in Down syndrome
- (2018) Andre Strydom et al. Alzheimers Research & Therapy
- Plasma Biomarkers Differentiate Parkinson’s Disease From Atypical Parkinsonism Syndromes
- (2018) Chin-Hsien Lin et al. Frontiers in Aging Neuroscience
- Promising Metabolite Profiles in the Plasma and CSF of Early Clinical Parkinson's Disease
- (2018) Daniel Stoessel et al. Frontiers in Aging Neuroscience
- Association of Changes in Plasma Neurofilament Light and Tau Levels With Anesthesia and Surgery
- (2018) Lisbeth Evered et al. JAMA Neurology
- α-Synuclein Heterocomplexes with β-Amyloid Are Increased in Red Blood Cells of Parkinson’s Disease Patients and Correlate with Disease Severity
- (2018) Simona Daniele et al. Frontiers in Molecular Neuroscience
- Rapid and ultra-sensitive quantitation of disease-associated α-synuclein seeds in brain and cerebrospinal fluid by αSyn RT-QuIC
- (2018) Bradley R. Groveman et al. Acta Neuropathologica Communications
- Validation of a Multiplex Assay for Simultaneous Quantification of Amyloid-β Peptide Species in Human Plasma with Utility for Measurements in Studies of Alzheimer's Disease Therapeutics
- (2018) D. Richard Lachno et al. JOURNAL OF ALZHEIMERS DISEASE
- Cerebrospinal Fluid Levels of Heart Fatty Acid Binding Protein are Elevated Prodromally in Alzheimer's Disease and Vascular Dementia
- (2018) Bob Olsson et al. JOURNAL OF ALZHEIMERS DISEASE
- A Selected Reaction Monitoring (SRM)-Based Method for Absolute Quantification of Aβ38, Aβ40, and Aβ42 in Cerebrospinal Fluid of Alzheimer's Disease Patients and Healthy Controls
- (2018) Josef Pannee et al. JOURNAL OF ALZHEIMERS DISEASE
- Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study
- (2018) Juan Fortea et al. LANCET NEUROLOGY
- Neurofilaments as biomarkers in neurological disorders
- (2018) Michael Khalil et al. Nature Reviews Neurology
- 18F-AV-1451 in Parkinson’s Disease with and without dementia and in Dementia with Lewy Bodies
- (2018) Ruben Smith et al. Scientific Reports
- Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
- (2018) Piotr Lewczuk et al. Alzheimers Research & Therapy
- Clustering Analysis of FDG-PET Imaging in Primary Progressive Aphasia
- (2018) Jordi A. Matias-Guiu et al. Frontiers in Aging Neuroscience
- Current state of Alzheimer’s fluid biomarkers
- (2018) José Luis Molinuevo et al. ACTA NEUROPATHOLOGICA
- Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer’s disease
- (2018) Claudia Cicognola et al. ACTA NEUROPATHOLOGICA
- Learnings about the complexity of extracellular tau aid development of a blood-based screen for Alzheimer's disease
- (2018) Zhicheng Chen et al. Alzheimers & Dementia
- Elevated CSF GAP-43 is Alzheimer's disease specific and associated with tau and amyloid pathology
- (2018) Åsa Sandelius et al. Alzheimers & Dementia
- Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis
- (2018) Federico Verde et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Biomarkers for tau pathology
- (2018) Michael Schöll et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic
- (2018) Harald Hampel et al. Nature Reviews Neurology
- Review: Fluid biomarkers for frontotemporal dementias
- (2018) H. Zetterberg et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Plasma Protein Biomarkers for the Prediction of CSF Amyloid and Tau and [18F]-Flutemetamol PET Scan Result
- (2018) Sarah Westwood et al. Frontiers in Aging Neuroscience
- Magnetic resonance imaging for the diagnosis of Parkinson’s disease
- (2017) Beatrice Heim et al. JOURNAL OF NEURAL TRANSMISSION
- Peripheral inflammation in prodromal Alzheimer’s and Lewy body dementias
- (2017) Eleanor King et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Plasma α-synuclein predicts cognitive decline in Parkinson’s disease
- (2017) Chin-Hsien Lin et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Patterns of atrophy in pathologically confirmed dementias: a voxelwise analysis
- (2017) Lorna Harper et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Comparison of elevated phosphorylated neurofilament heavy chains in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis
- (2017) Maxim De Schaepdryver et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- 18F-FDG PET in Parkinsonism: Differential Diagnosis and Evaluation of Cognitive Impairment
- (2017) Philipp T. Meyer et al. JOURNAL OF NUCLEAR MEDICINE
- Reduced mitochondrial mRNA expression in dementia with Lewy bodies
- (2017) Michele Salemi et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer’s disease and down syndrome
- (2017) Harutsugu Tatebe et al. Molecular Neurodegeneration
- Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
- (2017) Günter U. Höglinger et al. MOVEMENT DISORDERS
- Profiling novel metabolic biomarkers for Parkinson's disease using in-depth metabolomic analysis
- (2017) Wei Han et al. MOVEMENT DISORDERS
- Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson's disease: A systematic review and meta-analysis
- (2017) Paolo Eusebi et al. MOVEMENT DISORDERS
- Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod
- (2017) Fredrik Piehl et al. Multiple Sclerosis Journal
- [18F]FDG PET signal is driven by astroglial glutamate transport
- (2017) Eduardo R Zimmer et al. NATURE NEUROSCIENCE
- Cognitive decline in Parkinson disease
- (2017) Dag Aarsland et al. Nature Reviews Neurology
- Serum neurofilament light is sensitive to active cerebral small vessel disease
- (2017) Thomas Gattringer et al. NEUROLOGY
- Analysis of blood-based gene expression in idiopathic Parkinson disease
- (2017) Ron Shamir et al. NEUROLOGY
- Diagnosis and management of dementia with Lewy bodies
- (2017) Ian G. McKeith et al. NEUROLOGY
- CSF neurofilament light chain and phosphorylated tau 181 predict disease progression in PSP
- (2017) Julio C. Rojas et al. NEUROLOGY
- Serum neurofilament light in familial Alzheimer disease
- (2017) Philip S.J. Weston et al. NEUROLOGY
- Monitoring disease activity in multiple sclerosis using serum neurofilament light protein
- (2017) Lenka Novakova et al. NEUROLOGY
- Blood-based NfL
- (2017) Oskar Hansson et al. NEUROLOGY
- Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis
- (2017) Emily Feneberg et al. NEUROLOGY
- Serum neurofilament light as a biomarker for mild traumatic brain injury in contact sports
- (2017) Pashtun Shahim et al. NEUROLOGY
- Review: Tau in biofluids - relation to pathology, imaging and clinical features
- (2017) H. Zetterberg NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders
- (2017) Simon Sjödin et al. Proteomics Clinical Applications
- Analytical performance of reagent for assaying tau protein in human plasma and feasibility study screening neurodegenerative diseases
- (2017) Shieh-Yueh Yang et al. Scientific Reports
- High diagnostic value of second generation CSF RT-QuIC across the wide spectrum of CJD prions
- (2017) Alessia Franceschini et al. Scientific Reports
- Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases
- (2017) Kira S. Sheinerman et al. Alzheimers Research & Therapy
- Perspective Insights of Exosomes in Neurodegenerative Diseases: A Critical Appraisal
- (2017) Arif Tasleem Jan et al. Frontiers in Aging Neuroscience
- Association of Plasma Total Tau Level With Cognitive Decline and Risk of Mild Cognitive Impairment or Dementia in the Mayo Clinic Study on Aging
- (2017) Michelle M. Mielke et al. JAMA Neurology
- Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease
- (2017) Niklas Mattsson et al. JAMA Neurology
- Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod
- (2017) Fredrik Piehl et al. Multiple Sclerosis Journal
- Performance Characteristics of Plasma Amyloid-β 40 and 42 Assays
- (2017) Olivia I. Okereke et al. JOURNAL OF ALZHEIMERS DISEASE
- Posttranslational modifications of blood-derived alpha-synuclein as biochemical markers for Parkinson’s disease
- (2017) Hugo Vicente Miranda et al. Scientific Reports
- Monomethylated and unmethylated FUS exhibit increased binding to Transportin and distinguish FTLD-FUS from ALS-FUS
- (2016) Marc Suárez-Calvet et al. ACTA NEUROPATHOLOGICA
- In vivoimaging of neuromelanin in Parkinson’s disease using18F-AV-1451 PET
- (2016) Allan K. Hansen et al. BRAIN
- Different FDG-PET metabolic patterns at single-subject level in the behavioral variant of fronto-temporal dementia
- (2016) Chiara Cerami et al. CORTEX
- Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer’s disease
- (2016) Edward J. Goetzl et al. FASEB JOURNAL
- Cargo proteins of plasma astrocyte-derived exosomes in Alzheimer’s disease
- (2016) Edward J. Goetzl et al. FASEB JOURNAL
- Blood-Based Biomarker Candidates of Cerebral Amyloid Using PiB PET in Non-Demented Elderly
- (2016) Sarah Westwood et al. JOURNAL OF ALZHEIMERS DISEASE
- Cerebrospinal Fluid Alzheimer’s Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort
- (2016) Inger van Steenoven et al. JOURNAL OF ALZHEIMERS DISEASE
- Positron emission tomography imaging of tau pathology in progressive supranuclear palsy
- (2016) Sarah Coakeley et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Neurochemical biomarkers in the diagnosis of frontotemporal lobar degeneration: an update
- (2016) Patrick Oeckl et al. JOURNAL OF NEUROCHEMISTRY
- The clinical spectrum of sporadic and familial forms of frontotemporal dementia
- (2016) Ione O. C. Woollacott et al. JOURNAL OF NEUROCHEMISTRY
- Molecular neuropathology of frontotemporal dementia: insights into disease mechanisms from postmortem studies
- (2016) Ian R. A. Mackenzie et al. JOURNAL OF NEUROCHEMISTRY
- Neurofilament light chain in FTD is elevated not only in cerebrospinal fluid, but also in serum
- (2016) Carlo Wilke et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Altered Proteins in the Aging Brain
- (2016) Adila Elobeid et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
- (2016) Bob Olsson et al. LANCET NEUROLOGY
- Multi-platform mass spectrometry analysis of the CSF and plasma metabolomes of rigorously matched amyotrophic lateral sclerosis, Parkinson's disease and control subjects
- (2016) Anna Wuolikainen et al. Molecular BioSystems
- Imaging synucleinopathies
- (2016) David J. Brooks et al. MOVEMENT DISORDERS
- Increased basal ganglia binding of18F-AV-1451 in patients with progressive supranuclear palsy
- (2016) Ruben Smith et al. MOVEMENT DISORDERS
- Extracellular vesicles in neurodegenerative disease — pathogenesis to biomarkers
- (2016) Alexander G. Thompson et al. Nature Reviews Neurology
- A comparative study of the amount of α-synuclein in ischemic stroke and Parkinson’s disease
- (2016) Hui-Qing Zhao et al. NEUROLOGICAL SCIENCES
- Plasma tau in Alzheimer disease
- (2016) Niklas Mattsson et al. NEUROLOGY
- Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia
- (2016) Jonathan D. Rohrer et al. NEUROLOGY
- DNA methylation changes atSNCAintron 1 in patients with dementia with Lewy bodies
- (2016) Yu Funahashi et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer’s disease
- (2016) Annika Öhrfelt et al. Alzheimers Research & Therapy
- Plasma neuronal exosomal levels of Alzheimer's disease biomarkers in normal aging
- (2016) Erin L. Abner et al. Annals of Clinical and Translational Neurology
- Plasma neurofilament light chain predicts progression in progressive supranuclear palsy
- (2016) Julio C. Rojas et al. Annals of Clinical and Translational Neurology
- Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies
- (2016) Graham Fairfoul et al. Annals of Clinical and Translational Neurology
- Neurofilament light chain: a biomarker for genetic frontotemporal dementia
- (2016) Lieke H. Meeter et al. Annals of Clinical and Translational Neurology
- The Genetic Basis of Cognitive Impairment and Dementia in Parkinson’s Disease
- (2016) Lucy M. Collins et al. Frontiers in Psychiatry
- Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study
- (2016) Magnus Gisslén et al. EBioMedicine
- miRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer’s disease and other types of dementia – an exploratory study
- (2016) Sofie Sølvsten Sørensen et al. Translational Neurodegeneration
- An autoradiographic evaluation of AV-1451 Tau PET in dementia
- (2016) Val J. Lowe et al. Acta Neuropathologica Communications
- Plasma β-amyloid in Alzheimer’s disease and vascular disease
- (2016) Shorena Janelidze et al. Scientific Reports
- Neurofilaments in blood and CSF for diagnosis and prediction of onset in Creutzfeldt-Jakob disease
- (2016) Petra Steinacker et al. Scientific Reports
- Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease
- (2015) Hlin Kvartsberg et al. Alzheimers & Dementia
- C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease
- (2015) Ann De Vos et al. Alzheimers & Dementia
- Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study
- (2015) Massimo S. Fiandaca et al. Alzheimers & Dementia
- MicroRNA association with synucleinopathy conversion in rapid eye movement behavior disorder
- (2015) Rubén Fernández-Santiago et al. ANNALS OF NEUROLOGY
- Oligomeric α-synuclein and β-amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases
- (2015) Stephanie M. Williams et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Visual and statistical analysis of 18F-FDG PET in primary progressive aphasia
- (2015) Jordi A. Matías-Guiu et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural-derived blood exosomes of preclinical Alzheimer’s disease
- (2015) Dimitrios Kapogiannis et al. FASEB JOURNAL
- Identification of novel biomarkers for Parkinson's disease by metabolomic technologies
- (2015) Taku Hatano et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Frontotemporal dementia
- (2015) Jee Bang et al. LANCET
- Integrated isolation and quantitative analysis of exosome shuttled proteins and nucleic acids using immunocapture approaches
- (2015) Natasa Zarovni et al. METHODS
- Cerebrospinal Fluid Peptides as Potential Parkinson Disease Biomarkers: A Staged Pipeline for Discovery and Validation
- (2015) Min Shi et al. MOLECULAR & CELLULAR PROTEOMICS
- Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay
- (2015) Wendy E. Heywood et al. Molecular Neurodegeneration
- Amyloid deposition in Parkinson's disease and cognitive impairment: A systematic review
- (2015) Myria Petrou et al. MOVEMENT DISORDERS
- MDS clinical diagnostic criteria for Parkinson's disease
- (2015) Ronald B. Postuma et al. MOVEMENT DISORDERS
- Clearance systems in the brain—implications for Alzheimer disease
- (2015) Jenna M. Tarasoff-Conway et al. Nature Reviews Neurology
- PET Radioligands Reveal the Basis of Dementia in Parkinson's Disease and Dementia with Lewy Bodies
- (2015) Stephen N. Gomperts et al. Neurodegenerative Diseases
- Detection of α-synuclein oligomers in red blood cells as a potential biomarker of Parkinson’s disease
- (2015) Xuemei Wang et al. NEUROSCIENCE LETTERS
- Tissue-based map of the human proteome
- (2015) M. Uhlen et al. SCIENCE
- Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer’s disease patients and healthy controls
- (2015) Hlin Kvartsberg et al. Alzheimers Research & Therapy
- Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease
- (2015) Maartje I. Kester et al. JAMA Neurology
- Exosome and Exosomal MicroRNA: Trafficking, Sorting, and Function
- (2015) Jian Zhang et al. GENOMICS PROTEOMICS & BIOINFORMATICS
- Decrease in Plasma Levels of α-Synuclein Is Evident in Patients with Parkinson’s Disease after Elimination of Heterophilic Antibody Interference
- (2015) Ryotaro Ishii et al. PLoS One
- Levels and Age Dependency of Neurofilament Light and Glial Fibrillary Acidic Protein in Healthy Individuals and Their Relation to the Brain Parenchymal Fraction
- (2015) Mattias Vågberg et al. PLoS One
- Alpha-synuclein in peripheral tissues and body fluids as a biomarker for Parkinson's disease - a systematic review
- (2014) N. Malek et al. ACTA NEUROLOGICA SCANDINAVICA
- Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease
- (2014) Min Shi et al. ACTA NEUROPATHOLOGICA
- Plasma proteins predict conversion to dementia from prodromal disease
- (2014) Abdul Hye et al. Alzheimers & Dementia
- Cerebrospinal fluid alpha-synuclein as a biomarker for Parkinson's disease diagnosis: a systematic review and meta-analysis
- (2014) Liang Gao et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Divergent CSF alterations in two common tauopathies: Alzheimer's disease and progressive supranuclear palsy
- (2014) D. Wagshal et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
- (2014) Bruno Dubois et al. LANCET NEUROLOGY
- SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer’s disease
- (2014) Ann Brinkmalm et al. Molecular Neurodegeneration
- Plasma phospholipids identify antecedent memory impairment in older adults
- (2014) Mark Mapstone et al. NATURE MEDICINE
- Frontotemporal Lobar Degeneration: A Clinical Approach
- (2014) Elissaios Karageorgiou et al. SEMINARS IN NEUROLOGY
- The role of extracellular vesicles in the progression of neurodegenerative disease and cancer
- (2014) Kate M. Candelario et al. TRENDS IN MOLECULAR MEDICINE
- Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson’s disease with dementia and dementia with Lewy bodies compared to Alzheimer’s disease
- (2014) Oskar Hansson et al. Alzheimers Research & Therapy
- Limited role of free TDP-43 as a diagnostic tool in neurodegenerative diseases
- (2014) Emily Feneberg et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Blood Biomarkers for Brain Injury in Concussed Professional Ice Hockey Players
- (2014) Pashtun Shahim et al. JAMA Neurology
- Increased microRNA-34c abundance in Alzheimer's disease circulating blood plasma
- (2014) Shephali Bhatnagar et al. Frontiers in Molecular Neuroscience
- Heterophilic antibody interference in immunometric assays
- (2013) Nils Bolstad et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Distinct α-Synuclein Strains Differentially Promote Tau Inclusions in Neurons
- (2013) Jing L. Guo et al. CELL
- The impact of pre-analytical variables on the stability of neurofilament proteins in CSF, determined by a novel validated SinglePlex Luminex assay and ELISA
- (2013) Marleen J.A. Koel-Simmelink et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutation
- (2013) M. Suarez-Calvet et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Circulating miR-125b as a biomarker of Alzheimer's disease
- (2013) Lin Tan et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Heart fatty acid binding protein and Aβ-associated Alzheimer’s neurodegeneration
- (2013) Rahul S Desikan et al. Molecular Neurodegeneration
- A blood-based predictor for neocortical Aβ burden in Alzheimer’s disease: results from the AIBL study
- (2013) S C Burnham et al. MOLECULAR PSYCHIATRY
- 3-hydroxykynurenine and other Parkinson's disease biomarkers discovered by metabolomic analysis
- (2013) Peter A. LeWitt et al. MOVEMENT DISORDERS
- A comparative study of CSF neurofilament light and heavy chain protein in MS
- (2013) Jens Kuhle et al. Multiple Sclerosis Journal
- Autonomic disorders predicting Parkinson's disease
- (2013) Jose-Alberto Palma et al. PARKINSONISM & RELATED DISORDERS
- Identification of Altered Metabolic Pathways in Plasma and CSF in Mild Cognitive Impairment and Alzheimer’s Disease Using Metabolomics
- (2013) Eugenia Trushina et al. PLoS One
- Circulating miRNA Biomarkers for Alzheimer's Disease
- (2013) Pavan Kumar et al. PLoS One
- A longitudinal study on α-synuclein in blood plasma as a biomarker for Parkinson's disease
- (2013) Penelope G. Foulds et al. Scientific Reports
- Plasma tau levels in Alzheimer's disease
- (2013) Henrik Zetterberg et al. Alzheimers Research & Therapy
- A blood based 12-miRNA signature of Alzheimer disease patients
- (2013) Petra Leidinger et al. GENOME BIOLOGY
- TDP-43 plasma levels are higher in amyotrophic lateral sclerosis
- (2012) Esther Verstraete et al. Amyotrophic Lateral Sclerosis
- Neuropathologic substrates of Parkinson disease dementia
- (2012) David J. Irwin et al. ANNALS OF NEUROLOGY
- Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders
- (2012) Sara Hall et al. ARCHIVES OF NEUROLOGY
- Arginine methylation next to the PY-NLS modulates Transportin binding and nuclear import of FUS
- (2012) Dorothee Dormann et al. EMBO JOURNAL
- Increased 3-Hydroxykynurenine serum concentrations differentiate Alzheimer’s disease patients from controls
- (2012) Markus J. Schwarz et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes
- (2012) Bow J. Tauro et al. METHODS
- Brain amyloid and cognition in Lewy body diseases
- (2012) Stephen N. Gomperts et al. MOVEMENT DISORDERS
- Plasma Based Markers of [11C] PiB-PET Brain Amyloid Burden
- (2012) Steven John Kiddle et al. PLoS One
- Tau proteins in serum predict neurological outcome after hypoxic brain injury from cardiac arrest: Results of a pilot study
- (2012) Jeffrey Randall et al. RESUSCITATION
- Application of metabolomics approaches to the study of respiratory diseases
- (2012) Stuart Snowden et al. Bioanalysis
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Marilyn S. Albert et al. Alzheimers & Dementia
- Quantitative proteomic analysis of serum proteins in patients with Parkinson’s disease using an isobaric tag for relative and absolute quantification labeling, two-dimensional liquid chromatography, and tandem mass spectrometry
- (2011) Xiaping Zhang et al. ANALYST
- Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
- (2011) Katya Rascovsky et al. BRAIN
- Amyloid P component as a plasma marker for Parkinson's disease identified by a proteomic approach
- (2011) Han-Min Chen et al. CLINICAL BIOCHEMISTRY
- Diagnostic Accuracy of Plasma Glial Fibrillary Acidic Protein for Differentiating Intracerebral Hemorrhage and Cerebral Ischemia in Patients with Symptoms of Acute Stroke
- (2011) C. Foerch et al. CLINICAL CHEMISTRY
- Serum tau protein as a marker for the diagnosis of Creutzfeldt-Jakob disease
- (2011) Moeko Noguchi-Shinohara et al. JOURNAL OF NEUROLOGY
- Amyloid Imaging with 18F-Florbetaben in Alzheimer Disease and Other Dementias
- (2011) V. L. Villemagne et al. JOURNAL OF NUCLEAR MEDICINE
- Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration
- (2011) Edward B. Lee et al. NATURE REVIEWS NEUROSCIENCE
- Amyloid-related biomarkers and axonal damage proteins in parkinsonian syndromes
- (2011) Sara Bech et al. PARKINSONISM & RELATED DISORDERS
- Metabolomics in Early Alzheimer's Disease: Identification of Altered Plasma Sphingolipidome Using Shotgun Lipidomics
- (2011) Xianlin Han et al. PLoS One
- Plasma Biomarkers of Brain Atrophy in Alzheimer's Disease
- (2011) Madhav Thambisetty et al. PLoS One
- Metabolome in progression to Alzheimer's disease
- (2011) M Orešič et al. Translational Psychiatry
- Kynurenine and its metabolites in Alzheimer's disease patients
- (2010) E Gulaj et al. Advances in Medical Sciences
- Metabolomic changes in autopsy-confirmed Alzheimer's disease
- (2010) Rima Kaddurah-Daouk et al. Alzheimers & Dementia
- Parkinson's disease dementia: Definitions, guidelines, and research perspectives in diagnosis
- (2010) Christopher G. Goetz et al. ANNALS OF NEUROLOGY
- Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab
- (2010) Martin Gunnarsson et al. ANNALS OF NEUROLOGY
- Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease
- (2010) Annika Thorsell et al. BRAIN RESEARCH
- Brain-specific fatty acid-binding protein is elevated in serum of patients with dementia-related diseases
- (2010) C. E. Teunissen et al. EUROPEAN JOURNAL OF NEUROLOGY
- The cognitive profile and CSF biomarkers in dementia with Lewy bodies and Parkinson's disease dementia
- (2010) M. Andersson et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Differential levels of -synuclein, -amyloid42 and tau in CSF between patients with dementia with Lewy bodies and Alzheimer's disease
- (2010) K. Kasuga et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Potential of advanced MR imaging techniques in the differential diagnosis of parkinsonism
- (2010) Anna Hotter et al. MOVEMENT DISORDERS
- Significance of MRI in Diagnosis and Differential Diagnosis of Parkinson’s Disease
- (2010) Philipp Mahlknecht et al. Neurodegenerative Diseases
- Plasma phosphorylated-TDP-43 protein levels correlate with brain pathology in frontotemporal lobar degeneration
- (2009) Penelope G. Foulds et al. ACTA NEUROPATHOLOGICA
- Approaching clinical proteomics: current state and future fields of application in fluid proteomics
- (2009) Rolf Apweiler et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Neuroprotective effects of naturally occurring polyphenols on quinolinic acid-induced excitotoxicity in human neurons
- (2009) Nady Braidy et al. FEBS Journal
- Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI)
- (2009) Jessica B.S. Langbaum et al. NEUROIMAGE
- Differential diagnosis of parkinsonian syndromes using PCA-based functional imaging features
- (2009) Phoebe G. Spetsieris et al. NEUROIMAGE
- Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6
- (2009) C. Vance et al. SCIENCE
- Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis
- (2009) T. J. Kwiatkowski et al. SCIENCE
- TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer’s disease and frontotemporal lobar degeneration
- (2008) Penelope Foulds et al. ACTA NEUROPATHOLOGICA
- CSF Multianalyte Profile Distinguishes Alzheimer and Parkinson Diseases
- (2008) Jing Zhang et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- TDP-43 in Cerebrospinal Fluid of Patients With Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
- (2008) Petra Steinacker et al. ARCHIVES OF NEUROLOGY
- Metabolomic profiling to develop blood biomarkers for Parkinson's disease
- (2008) M. Bogdanov et al. BRAIN
- Individual cerebral metabolic deficits in Alzheimer’s disease and amnestic mild cognitive impairment: an FDG PET study
- (2008) Angelo Del Sole et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography
- (2008) P Edison et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Evaluation of plasma Aβ40 and Aβ42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment
- (2008) Oskar Hansson et al. NEUROBIOLOGY OF AGING
- Imaging amyloid deposition in Lewy body diseases
- (2008) S. N. Gomperts et al. NEUROLOGY
- Uric acid associates with cognition in Parkinson's disease
- (2008) Tua Annanmaki et al. PARKINSONISM & RELATED DISORDERS
- Stability of Pro-Gastrin-Releasing Peptide in Serum versus Plasma
- (2008) Toru Yoshimura et al. TUMOR BIOLOGY
- Serum heart-fatty acid binding protein levels in patients with Lewy body disease
- (2007) Kenji Wada-Isoe et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started